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The mechanisms by which cytotoxic T lymphocytes
(CTLs) enter and are retained in nonlymphoid tissue
are not well characterized. With a transgenic mouse
expressing the NKG2D ligand retinoic acid early tran-
script 1ε (RAE1ε) in b-islet cells of the pancreas, we
found that RAE1 expression was sufficient to induce
the recruitment of adoptively transferred CTLs to
islets. This was dependent on NKG2D expression
by the CTLs and independent of antigen recognition.
Surprisingly, the recruitment of CTLs resulted in the
subsequent recruitment of a large number of endog-
enous lymphocytes. Whereas transgenic mice did
not develop diabetes, RAE1 expression was suffi-
cient to induce insulitis in older, unmanipulated
transgenic mice that was enhanced by viral infection
and pancreatic inflammation. These results demon-
strate that the expression of an NKG2D ligand in
islets is sufficient to recruit CTLs regardless of their
antigen specificity and to induce insulitis.
INTRODUCTION
The expression of NKG2D ligands on b-islet cells of the
pancreas is proposed to play a key role in the pathogenesis of
type 1 diabetes. In the human, genetic linkage studies demon-
strate a positive association between a polymorphism in the
gene encoding NKG2D ligandMHC class 1 chain-related protein
A (MICA) and autoimmune diabetes (Nikitina-Zake et al., 2004),
and altered NKG2D expression is observed in type 1 diabetic
patients (Rodacki et al., 2007). In the nonobese diabetic (NOD)
mouse model, the NKG2D ligand retinoic acid early transcript 1
(RAE1) was detected on b-islet cells, and treatment with a block-
ing NKG2D antibody in this model inhibited CD8+ T cell in-
filtration into islets and diabetes development (Ogasawara
et al., 2004). These data suggest that NKG2D expression in the
pancreas may be a causative step in the development of autoim-
mune diabetes via engagement of NKG2D on CD8+ T cells.
However, it was unclear how NKG2D would function in this
setting.132 Immunity 36, 132–141, January 27, 2012 ª2012 Elsevier Inc.NKG2D is expressed by all natural killer (NK) cells in both
human and mouse (Bauer et al., 1999; Wu et al., 1999) and on
subsets of T cells. In the human this includes all CD8+ T cells
(Bauer et al., 1999), all gd T cells (Bauer et al., 1999), NKT cells,
and small subsets of CD4+ T cells (Dai et al., 2009; Groh et al.,
2003, 2006). In the mouse NKG2D expression is limited to acti-
vated (not naive) CD8+ T cells (Jamieson et al., 2002), subsets
of gd T cells (Jamieson et al., 2002), NKT cells, and a small
number of CD4+ T cells (Hyka-Nouspikel et al., 2007).
NKG2D binds to a wide variety of ligands, all of which are
related to MHC class I in sequence. In the human, the ligands
are MICA and MICB (Bauer et al., 1999) and the UL-16 binding
protein (ULBP), or retinoic acid early transcript 1 (RAET1) family
member molecules (Bacon et al., 2004; Chalupny et al., 2003;
Cosman et al., 2001). In the mouse, the ligands include the
RAE1 (RAE1aε) protein family, the H60 (H60a-c) proteins, and
mouse UL16-binding protein-like transcript 1 (MULT1) (Carayan-
nopoulos et al., 2002a; Cerwenka et al., 2000; Diefenbach et al.,
2000, 2003; Takada et al., 2008; Whang et al., 2009). These
ligands are thought to be expressed not in most normal tissue,
but rather their expression is induced under conditions of cell
stress, such as viral infection, cellular transformation, or DNA
damage (reviewed in Champsaur and Lanier, 2010).
In NK cells, NKG2D is an activating receptor, with engagement
of NKG2D leading to cell killing (Bauer et al., 1999; Wu et al.,
1999). In contrast, the function of NKG2D on CD8+ T cells
is less clear. Most studies suggest that NKG2D can act as
a costimulatory receptor for cytotoxic T lymphocytes (CTLs),
enhancing T cell receptor (TCR)-driven responses (Bauer et al.,
1999; Chalupny et al., 2003; Cosman et al., 2001; Diefenbach
et al., 2000; Markiewicz et al., 2005; Sutherland et al., 2002).
However, other studies suggest that NKG2D alone has no effect
on T cell activation (Champsaur and Lanier, 2010; Ehrlich et al.,
2005). Our own studies of NKG2D function on T cells (Cemerski
et al., 2007;Markiewicz et al., 2005) support the idea that NKG2D
can costimulate T cells, but that it can also have functions inde-
pendent of antigen recognition. Namely, we showed that NKG2D
engagement could induce immunological synapse formation in
CTLs independent of antigen. The significance of this finding
was unclear, because NKG2D-mediated synapse formation
did not result in activation of CTLs.
The recruitment of CTLs into tissue plays a critical role in
the immunity to pathogens and also in the pathogenesis of
Figure 1. Specific Expression of RAE1ε in b-Islet Cells of RIP-RAE1ε
Mice
(A) Pancreases from RIP-RAE1ε, RIP-Cre, and PCCALL-RAE1ε mice were
sectioned and stained with a RAE1ε-specific antibody (red) and nuclei
counterstained with Hoescht (blue).
(B) Serial sections of those shown in (A) were stained with H&E.
See also Figure S1.
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Antigen-Independent Recruitment of CTLautoimmune diseases. The rules that govern the ability of CTLs
to enter and remain in nonlymphoid tissues are complex and
may be different for individual tissues. CTLs appear to have unre-
stricted access to many tissues (Masopust et al., 2004), but
secondary signals, such as chemokine secretion from T helper
cells, can enhanceCTL access to tissues like the vaginal mucosa
(Nakanishi et al., 2009). With respect to the pancreas, two recent
reports suggest that islet-antigen specificity is required for the
recruitment of both CD4+ and CD8+ T cells to islets (Lennon
et al., 2009; Wang et al., 2010). However, the data suggesting
that interaction between NKG2D and its ligands is required for
CD8+ T cell recruitment to islets in NOD mice (Ogasawara
et al., 2004) led us to hypothesize that NKG2D may function to
attract CTLs to pancreatic islets in diabetic individuals where
its ligands are expressed.
To address our hypothesis, we generated a transgenic mouse
with expression of the NKG2D ligand RAEε in pancreatic islets.
We found that RAE1ε expression allowed for the specific re-
cruitment of adoptively transferred CTLs to pancreatic islets
independent of antigen recognition by the T cells. Demonstrating
that this recruitment was through engagement of NKG2D on the
CTLs, NKG2D-deficient CTLs were not recruited. Interestingly,
this recruitment of CTLs resulted in the subsequent recruitment
of endogenous lymphocytes via chemokine expression in the
islets. Additionally, a mild insulitis, made up largely of lympho-
cytes, developed spontaneously in older transgenic mice that
could be worsened by inducing pancreatic inflammation and
increasing CTL numbers in the mice. Taken together, these
results demonstrate that sterile expression of NKG2D ligands
on b-islet cells can lead to antigen-independent CTL recruitment
and insulitis. This suggests that aberrant NKG2D ligand expres-
sion by islet cells could be an initial trigger for lymphocyte recruit-
ment during the development of autoimmune diabetes.
RESULTS
Generation of Transgenic Mice with Constitutive RAE1ε
Expression in Pancreatic Islets
The expression of RAE1 in the b cells of the islet is suggested to
be an initial trigger for the development of diabetes in the NOD
mouse (Ogasawara et al., 2004). We hypothesized this may be
via CTL recruitment to the pancreas. To test this hypothesis,
we generated a conditional transgenic mouse in which expres-
sion of RAE1ε is controlled by the tissue-specific expression
of Cre recombinase (Figure 1; Figure S1 available online). We
cloned the RAE1ε cDNA into a plasmid (pCCALL2) that contains
the constitutive chicken b-actin promoter, followed by a loxP-
flanked gene encoding b-galactosidase-Neomycin (b-geo) (No-
vak et al., 2000). In the presence of Cre, the gene encoding
b-geo is removed, allowing for RAE1ε expression. The construct
was electroporated into embryonic stem (ES) cells and clones
were screened for the expression of b-galactosidase as well as
expression of RAE1ε after transient expression of Cre. Blasto-
cyst injection was used to generate a transgenic mouse line.
We confirmed the expression of b-galactosidase activity in
most tissues in this mouse line (data not shown).
To induce the constitutive expression of RAE1ε in the b cells of
the pancreatic islets, we bred the pCCALL2-RAE1εmice to mice
expressing Cre recombinase under the control of the rat insulinpromoter (RIP-Cre) (Postic et al., 1999). We easily detected
RAE1ε expression in double-transgenic (RIP-RAE1ε), but not
single-transgenic (pCCALL2-RAE1εorRIP-CRE),mice (Figure1).
Importantly, unlike transgenic models in which NKG2D ligands
are expressed ubiquitously (Coudert et al., 2008; Oppenheim
et al., 2005; Wiemann et al., 2005), the level of NKG2D expres-
sion on splenic NK cells was unaffected in RIP-RAE1ε mice
(data not shown).
Antigen-Independent Recruitment of CTLs
to RAE1ε-Expressing Islets via NKG2D
The expression of RAE1 in the b-islet cells of NOD mice is
thought to potentiate injury mediated by NKG2D-expressing
CD8+ T cells (Ogasawara et al., 2004). Because of the ability of
NKG2D engagement to induce CTL synapse formation (Markie-
wicz et al., 2005), we hypothesized that expression of RAE1ε in
islets might function to capture and retain NKG2D+ CTLs in the
pancreas in an antigen-independent manner. To directly test
this, we adoptively transferred ovalbumin (OVA)-specific CTLs
(OT-I) with the assumption that this TCR has no reactivity against
any antigen in the islet. In-vitro-generatedOT-I CTLs (Figure S2A)
were labeled with CFSE and then adoptively transferred into
RIP-RAE1ε or control (RIP-Cre and pCCALL2-RAE1ε) mice. As
a positive control, OT-I CTLs were transferred into transgenic
mice with OVA expression in the islets (RIP-OVA) (Kurts et al.,
1996). Twenty-four hours later, islets were purified and single-
cell suspensions analyzed for the presence of the CFSE-labeled
CTLs. We detected transferred CTLs in the double-transgenic
mice and RIP-OVA mice, but not in the single-transgenic control
mice (Figures 2, S2C, and S2D). The presence of similar numbers
of CFSE-labeled CTLs in the spleen of all mice verified that
the mice had received similar numbers of CTL (Figure 2A).Immunity 36, 132–141, January 27, 2012 ª2012 Elsevier Inc. 133
Figure 2. Antigen-Independent Recruitment of Adoptively Trans-
ferred CTLs to Islets of Mice with b-Islet Cell-Specific RAE1ε
Expression
(A) Flow cytometric plots demonstrate the presence of adoptively transferred
OT-I CTLs (CFSE+CD3+) in purified islets (top) from RIP-RAE1ε and RIP-OVA
but not control mice. The plots shown are gated on live (7-AAD) cells. Similar
analyses demonstrated similar numbers of CFSE+ cells present in the spleens
(bottom). The numbers shown are the total number of transferred CTLs present
in the organ per mouse.
(B) The number of adoptively transferred OT-I CTLs (±SEM) present in purified
islets per mouse from RIP-RAE1ε, RIP-OVA, or PCCALL-RAE1ε and RIP-Cre
mice. The number shown is the average of eight independent experiments
(±SEM) (RIP-RAE1ε and control) or four independent experiments (RIP-OVA).
*p < 0.0001 in a two-sided Student’s t test.
See also Figure S2.
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Antigen-Independent Recruitment of CTLConfirmatory experiments done with OT-I CTLs generated from
RAG-1-deficient (Rag1/) mice ruled out any role for antigen
recognition in the recruitment of the CTL to islets in the RIP-
RAE1ε mice (Figures S2E and S2F).
To determine whether the recruitment of CTLs to the islets in
RIP-RAE1ε mice was dependent on NKG2D, we adoptively
transferred CFSE-labeled OT-I CTLs from DNAX-activating
protein of 10 KDa (DAP10)-deficient (Hcst/) mice. DAP10 is
an adaptor protein required for both NKG2D surface expression
and signaling on T cells (Gilfillan et al., 2002); Hcst/ CTLs
therefore do not express NKG2D on the surface, nor can they
be stimulated by NKG2D stimulation (Markiewicz et al., 2005).
Confirming that the recruitment of CTLs to the islets was depen-
dent on NKG2D expression, CFSE-labeled Hcst/ CTLs were
not detected in islets expressing RAE1ε (Figures 3A and 3B).
Experiments with OT-I CTLs generated from mice completely134 Immunity 36, 132–141, January 27, 2012 ª2012 Elsevier Inc.deficient in NKG2D (Klrk1/) (Zafirova et al., 2009) further
confirmed a requirement for NKG2D surface expression for
the recruitment of the adoptively transferred CTLs (Figure S3).
These results demonstrate that RAE1ε expression in islets can
recruit NKG2D-expressing CTLs in the absence of TCR recogni-
tion of antigen.
CTL Recruitment to RAE1ε-Expressing Islets Stimulates
the Recruitment of Endogenous Lymphocytes
During the flow cytometric analysis of the islets for the presence
of adoptively transferred CTLs, we noted that when CTLs were
detected in the islets, there was also amuch larger accumulation
of endogenous immune cells (Figures 3A and 3C). Flow cytomet-
ric analysis showed that this endogenous infiltrate was largely
composed of T lymphocytes (Figure 3C). Analysis of the single-
transgenic control mice after adoptive transfer of CTLs, as well
as analysis of the RIP-RAE1ε mice that received Hcst/ CTLs
or did not receive CTLs, showed few numbers of inflammatory
cells (Figure 3C). We did not detect NKG2D expression on any
of the infiltrating cells, suggesting that the recruitment of these
other cells was not mediated by the presence of RAE1 (data
not shown). This is not surprising because most murine CD4+
T cells and naive CD8+ cells don’t express NKG2D (Champsaur
and Lanier, 2010). Together, these results suggest that the
recruitment of the NKG2D-expressing CTLs stimulated the
recruitment of other T cells in an NKG2D-independent manner.
CTL Recruitment to RAE1ε-Expressing Islets Leads
to CCL5 Expression in Islets
We hypothesized that the recruitment of endogenous lympho-
cytes to RAE1-expressing islets after CTL recruitment was due
to the induction of chemokine expression in the islets. To test
this, we extracted RNA from islets purified from RIP-RAE1ε and
single-transgenic control mice that had received OT-I CTLs as
well as RIP-RAE1ε mice that did not receive T cells. We then
determined the chemokine genesdifferentially expressed among
the islets by using a PCR mouse chemokine array. We found
multiple chemokines upregulated in the islets purified from RIP-
RAE1ε adoptive transfer recipient mice compared with islets
purified from control adoptive transfer recipient mice or RIP-
RAE1εmice that did not receive CTLs, themost highly expressed
being CCL5 (RANTES) (Figure 4A and data not shown).
We next set out to determine which cell type was responsible
for chemokine expression in the islets of RAE1-expressing
adoptive transfer recipient mice. First, islets were purified from
RIP-RAE1ε mice that had or had not received OT-I CTLs,
single-cell suspensions were generated, the cells were sepa-
rated into CD45+ (immune) and CD45 (nonimmune) cell pop-
ulations, and the chemokines expressed by each of these
populations were determined. Multiple chemokine transcripts
were detected in both cell populations by this method, suggest-
ing that multiple cell types might be producing chemokines (Fig-
ure 4B). To determine whether any of these chemokines were
detectable at the protein level, purified islets were cultured over-
night and the supernatants analyzed for the presence of chemo-
kines. Only one chemokine, namely CCL5, was increased in the
supernatants of RAE1-expressing islets from CTL adoptive
transfer recipient mice compared with those from RAE1-
expressing islets that had not received CTLs or control mice
Figure 3. Recruitment of Endogenous Lympho-
cytes to Islets of Mice with b-Islet Cell-Specific
RAE1ε Expression after Recruitment of Adoptively
Transferred CTLs via NKG2D
(A) NKG2D is required for CTL recruitment to the islet. OT-I
CTLs were prepared from wild-type (WT) and Hcst/
mice and transferred after labeling with CFSE. Repre-
sentative flow cytometric plots demonstrate the presence
or absence of endogenous T cells (CD3+CFSE) and
adoptively transferred WT CTLs (CD3+CFSE+) (left two
columns) or Hcst/ CTLs (right two columns) in purified
islets (top) or spleens (bottom) from RIP-RAE1ε and
control PCCALL-RAE1ε and RIP-Cre mice. The numbers
shown are the total number of adoptively transferred CTLs
or endogenous T cells present per mouse.
(B) The number of adoptively transferred WT or Hcst/
OT-I CTLs (±SEM) present in purified islets per mouse
from RIP-RAE1ε mice. The number shown is the average
of three independent experiments (±SEM). *p < 0.0001 in
a two-sided Student’s t test.
(C) The number of endogenous T cells (CD3+CFSE) and
B cells (B220+) per mouse in purified islet preparations
from RIP-RAE1ε, RIP-OVA, or control OT-I CTL adoptive
transfer recipient mice, unmanipulated RIP-RAE1ε mice,
and RIP-RAE1ε Hcst/ OT-I CTL adoptive transfer
recipient mice. The number shown is the average (±SEM)
of seven independent experiments (RIP-RAE1ε and con-
trol) or three independent experiments (RIP-OVA).
See also Figure S3.
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Antigen-Independent Recruitment of CTLthat had received CTLs (Figure 4C). Given that CCL5 is a potent
T cell chemoattractant (Appay and Rowland-Jones, 2001), these
data suggest that CCL5 expression in the RAE1-expressing
adoptive transfer recipient mice was probably responsible for
the recruitment of endogenous T cells.
CCL5 is predominantly secreted by activated CD8+ T cells
(Appay and Rowland-Jones, 2001). Therefore, we wondered
whether the adoptively transferred CTLs themselves could be
responsible for the CCL5 production detectable in the RAE1-
expressing islets of CTL adoptive transfer recipients. Indeed,
CCL5 was detected in supernatants from overnight cultures of
OT-I CTL alone and this was not increased further by stimulation
throughNKG2D (Figure 4C and data not shown). Taken together,
these data suggest that CCL5 expression by the recruited OT-I
CTLs in the RAE1-expressing adoptive transfer recipient mice
was probably responsible for the subsequent recruitment of
endogenous T cells.
Transgenic Expression of RAE1ε in Islets Leads to
Lymphocytic Infiltrates into the Pancreas of Older Mice
Although young (up to 3months) RIP-RAE1εmice did not contain
pancreatic immune infiltrates in the absence of CTL transfer, we
wondered whether spontaneous lymphocyte recruitment could
occur as the mice aged. We hypothesized that this might then
lead to islet destruction and diabetes development. To testImmunity 36, 13this, we screenedRIP-RAE1εmice for the devel-
opment of diabetes by regular blood glucose
readings for up to 1 year. Over this period, we
did not detect any glucose abnormalities in
any of our double-transgenic mice. Histological
examination of older mice (8–10 months), how-ever, demonstrated that all RIP-RAE1εmice analyzed developed
a mild insulitis (nine of nine mice) (Figure 5). In contrast, little to
no insulitis was seen in PCCALL2-RAE1ε or RIP-Cre mice (Fig-
ure 5D) or in young (6–8 weeks) RIP-RAE1ε mice (data not
shown). To determine the composition of the inflammatory infil-
trate in older RIP-RAE1εmice, islets were isolated and analyzed
by flow cytometry (Figure 6). This analysis showed that the
immune infiltrates were a mixture of immune cells composed
mainly of lymphocytes (Figure 6C). These results demonstrate
that expression of RAE1 in the islets caused spontaneous
recruitment of lymphocytes and the development of a mild
insulitis.
Inflammation-Induced Infiltration of Lymphocytes
into RAE1ε-Expressing Islets
We hypothesized the lack of diabetes development in RIP-
RAE1ε mice could be due to poor access of lymphocytes to
uninflamed tissue. Our adoptive transfer experiments demon-
strated that RAE1 expression on b-islet cells was sufficient to
induce the recruitment of a small number of NKG2D-expressing
CTLs to the islets. We wondered whether inflammation could
increase CTL recruitment to islets further in RIP-RAE1ε mice.
To test this, we first treated young RIP-RAEε and singly
transgenic control mice with the b-islet cell-specific toxin
streptozotocin (STZ) to cause pancreatic inflammation prior to2–141, January 27, 2012 ª2012 Elsevier Inc. 135
Figure 4. CTL Recruitment to RAE1ε-Expressing Islets Results in
CCL5 Expression in Islets
(A) Differential chemokine gene expression in islets purified from RIP-RAE1ε
and control RAE1-negative (PCCALL-RAE1ε and RIP-Cre) mice that received
OT-I CTLs 24 hr previously. Genes upregulated greater than 3-fold are shown
in red circles and genes decreased more than 3-fold are shown in green
circles.
(B) Chemokine gene transcripts increased at least 3-fold in islets from RIP-
RAE1εmice that received OT-I CTLs compared with controls and the cell type
in which they were detected (average fold increase, n = 3).
(C) Levels of secreted CCL5 (average ± STD, n = 4) measured from islets
purified from RIP-RAE1ε or control OT-I CTL adoptive transfer recipient mice,
unmanipulated RIP-RAE1ε, or control mice, and OT-I CTL prior to adoptive
transfer. *p < 0.03; **ND (not detectable).
Figure 5. Mice with b-Islet Cell-Specific RAE1ε Expression Develop
a Mild Insulitis as They Age
(A and B) Examples of immune infiltrates (arrows) inside pancreatic islets of
two 8-month-old RIP-RAE1ε mice.
(C) The boxed portion of (B) magnified.
(D) The percentage of 8- to 10-month-old RIP-RAE1ε (n = 9), RIP-Cre (n = 7),
and PCCALL-RAE1ε (n = 3) mice analyzed with immune infiltrates in the
pancreas.
(E) The percentage of islets affected in the pancreata of the 8- to 10-month-old
RIP-RAE1ε mice shown in (D).
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Antigen-Independent Recruitment of CTLadoptive transfer of OT-I CTLs. Treatment with STZ resulted in
greater recruitment of both OT-I CTLs and endogenous T cells
to the islets of RIP-RAE1ε mice compared with untreated RIP-
RAE1ε mice or control mice (Figure 7A). These results suggest
that pancreatic damage and islet RAE1 expression can syner-
gize to induce the recruitment of T cells to the islets.
We next tested whether the increased T cell recruitment seen
in STZ-treated RIP-RAE1εmice could lead to the development of
overt diabetes. RIP-RAE1ε and singly transgenic control mice
were treated with a subdiabetic dose of STZ, blood glucose
levels were monitored weekly, and the mice were sacrificed after
6 weeks. Although none of the mice developed diabetes, flow
cytometric analysis of islets showed that the RIP-RAE1ε mice
were very sensitive to the low dose of STZ and developed
a greater inflammatory infiltrate compared to single-transgenic
controls (Figures 7B–7D). We wondered whether we could
enhance this infiltrate further by increasing the number of circu-136 Immunity 36, 132–141, January 27, 2012 ª2012 Elsevier Inc.lating CTLs in the mice. Therefore, to increase CTL numbers, we
infected RIP-RAE1ε and singly transgenic mice with influenza A
along with STZ treatment. RIP-RAE1ε mice infected with influ-
enza alone showed a larger inflammatory infiltrate than the
single-transgenic controls (Figures 7B–7D); however, the RIP-
RAE1ε mice that received both STZ as well as influenza devel-
oped the greatest lymphocyte recruitment (Figures 7B–7D).
These results suggest that the ability of islet-specific expression
of RAE1ε to induce considerable lymphocytic infiltration requires
both the presence of CTLs as well as an inflammatory stimulus
that enhances the recruitment of cells into the islet.
DISCUSSION
NKG2D and its ligands are implicated in autoimmune diabetes in
both humans and mice (Nikitina-Zake et al., 2004; Ogasawara
et al., 2004). However, it was not clear how NKG2D and
NKG2D ligands could contribute to diabetes development. Our
current study offers one possible mechanism. We demonstrate
that NKG2D engagement on CTLs with its ligands expressed
on islet cells can lead to the recruitment of the CTL to pancreatic
islets. Through the secretion of chemokine, this can then lead to
the recruitment of additional T cells that do not express NKG2D.
This suggests that at least one function of NKG2D in diabetes
may be to mediate the recruitment of T cells to pancreatic islets.
Figure 6. Inflammatory Infiltrate in Older RIP-RAE1ε Mice Is
Composed Largely of Lymphocytes
(A) Representative flow cytometry plot demonstrating the presence of
immune cells in islet preparations from RIP-RAE1εmice. Islets purified from an
8-month-old RIP-RAE1ε mouse was stained with a CD45-specific antibody.
The plot shown is gated on live (7-AAD) cells.
(B) The number of immune cells present in islet preparations from RIP-RAE1ε
mice compared with controls. Islets were purified from 8- to 10-month-old
RIP-RAEε and RIP-Cre and PCCALL-RAE1ε control mice and pooled within
groups. The islets were stained with aCD45-specific antibody and analyzed by
flow cytometry. The number of live (7-AAD) CD45+ cells present per mouse
was determined. The data shown is the average of four independent experi-
ments (±SEM) with a total of 14 animals in each group.
(C) The majority of cells present in islet preparations from older RIP-RAE1ε
mice are lymphocytes. The CD45+ cells shown in (B) were stained with anti-
bodies specific for CD8a, CD4, NK1.1, CD3ε, TCRgd, B220, Cd11b, and
CD11c and analyzed by flow cytometry. The percentage of CD45+ cells
present with the given cellular phenotype is shown. Abbreviations: CD8, CD8+
T cell; CD4, CD4+ T cell; NKT, NK T cell; gd, gd T cell; NK, NK cell; B, B cell;
mac, macrophage; DC, dendritic cell.
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Antigen-Independent Recruitment of CTLThe mechanisms by which CTLs are recruited to inflammatory
sites are only beginning to be characterized. Although once
thought to have unrestricted access to all tissues, it is now
becoming clear that CTLs require specific signals to enter certain
organs. Signals described to date include specific chemokine
expression in tissues after CD4+ T cell recruitment (Masopust
et al., 2004) and antigen recognition (Wang et al., 2010). Here
we demonstrate a mechanism by which CTLs can be recruited
to NKG2D ligand-expressing pancreatic islets. This recruitment
was dependent on NKG2D expression by the CTLs and indepen-
dent of cognate antigen recognition.
Although it was first realized that NKG2D was expressed on
CD8+ T cells 12 years ago (Bauer et al., 1999), the function of
NKG2D on CD8+ T cells is still being delineated. NKG2D wasoriginally described as a costimulatory receptor for CTLs (Groh
et al., 2001), with no function in the absence of coincident TCR
signaling. Since this time, NKG2D signaling on CTLs has been
demonstrated to have some function in the absence of antigen
recognition by the TCR under the correct conditions (Meresse
et al., 2004; Verneris et al., 2004). Our early studies demon-
strated that NKG2D engagement could induce immunological
synapse formation in CTLs independent of antigen (Markiewicz
et al., 2005). However, the significance of this finding was
unclear, because NKG2D-mediated synapse formation did not
result in any measurable CTL effector function. Our present
data suggest that this may lead to the accumulation of CTLs in
sites of NKG2D ligand expression in the absence of antigen
recognition by the TCR.
Unexpectedly, recruitment of CTLs to islets was accompanied
by amuch larger recruitment of additional lymphocytes. Chemo-
kine analysis showed that after T cell adoptive transfer, CCL5,
a potent T cell chemoattractant, was induced in RAE1-express-
ing islets. Given that the CTLs themselves secreted a large
amount of CCL5, this was probably what was responsible for
the recruitment of additional lymphocytes. We cannot conclude
from our studies whether the additional lymphocytes recruited
after NKG2D-mediated CTL recruitment were specific for islet
antigens or not. Nonetheless, RAE1 expression by islets led to
recruitment of cells triggered by an antigen-independent CTL
response.
Although insulitis was not seen in younger RIP-RAE1ε mice,
a mild insulitis did develop as the mice aged. The absence of
insulitis in youngmice suggests that despite constitutive expres-
sion of NKG2D by NK cells, NK cells are not able to traffic into
RAE1-expressing islets by themselves and/or require additional
factors to kill islet cells. Similar to our findings, Strid et al. (2008)
demonstrated that acute upregulation of RAE1-b in the epi-
dermis induced immune infiltration. However, in contrast to the
slower infiltration of immune cells we observed in the pancreas
of the RIP-RAE1ε mice, the acute expression of RAE1-b in skin
rapidly induced immune infiltration of CD4CD8 ab unconven-
tional T cells, a cell type that we did not observe in the pancreas.
It is not clear why the character of the infiltrate in response to
RAE1 expression is so different between these two models. It
could be a differential response in skin versus pancreas, to acute
versus chronic RAE1 expression, or to different RAE1 isoforms.
Additionally, the receptor responsive to RAE1-b in the epidermis
was not determined, so the response seen in the skin may have
involved a receptor in addition to NKG2D.
Because NKG2D is expressed only on CTLs and not on naive
CD8+ T cells, we suspected that the delayed development of in-
sulitis in our transgenic mice was due to low numbers of CTLs
present in our mice, which are maintained in specific-pathogen-
free conditions, and the absence of inflammation to promote cell
entry. We tested these hypotheses by treating mice with a small
dose of STZ to damage and inflame the islets. Although this dose
of STZ resulted in little to no cell infiltration in wild-type mice, it
was able to induce inflammation in RAE1-expressing mice. To
increase the number of CTLs, we infected mice with influenza
virus. Infection resulted in increased numbers of infiltrating
lymphocytes in the nontransgenic islet, suggesting that viral
infection may have multiple effects (including increasing CTL
numbers) that may allow for immune cell infiltration intoImmunity 36, 132–141, January 27, 2012 ª2012 Elsevier Inc. 137
Figure 7. Inflammation-Induced Recruitment of
Endogenous Lymphocytes to Islets of Mice with
b-Islet Cell-Specific RAE1ε Expression
(A) STZ treatment increases recruitment of T cells to islets.
RIP-RAE1ε and control PCCALL-RAE1ε and RIP-Cremice
were treated with STZ (2 doses of 75 mg/kg 24 hr apart),
and 107 CFSE-labeled OT-I CTLs were adoptively trans-
ferred along with the second dose of STZ. Twenty-four
hours later, the pancreases were harvested and pooled
within groups, and islets purified. Single-cell suspensions
of the purified islets were analyzed by flow cytometry. The
plots shown are gated on live (7-AAD) cells. The numbers
shown are the total number of transferred CTLs and
endogenous T cells present per mouse.
(B) STZ treatment and viral infection increase immune
infiltration into the pancreas of RIP-RAE1ε mice. Islets
were purified from RIP-RAE1ε or control PCCALL-RAE1ε
and RIP-Cre mice 6 weeks after STZ injection (2 doses of
50 mg/kg), intranasal infection with influenza A (100 PFU),
or both STZ treatment and influenza A infection. The islets
were stained with a CD45-specific antibody, analyzed by
flow cytometry, and the number of live (7-AAD) CD45+
cells present per mouse determined.
(C) The CD45+ cells shown in (B) were stained with anti-
bodies specific for CD3 and analyzed by flow cytometry.
(D) The CD45+ cells shown in (B) were stained with anti-
bodies specific for B220 and analyzed by flow cytometry.
The number of cells present per mouse is shown.
These results are representative of two independent
experiments.
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RAE1ε resulted in a moderately enhanced number of infiltrating
lymphocytes when the mice were infected with influenza.
Combining STZ and infection with influenza resulted in a syner-
gistic effect with a much greater lymphocyte infiltration detected
in RAE1ε-expressing animals compared to the single-transgenic
controls. This suggests that in the pathogenesis of diabetes,
a virus that could infect the islets and induce NKG2D ligand
expression might be able to both stimulate islet inflammation
as well as induce CTL infiltration.
Analysis of the pancreatic cellular infiltrate in older RIP-RAE1ε
mice demonstrated that CTLs constituted only a minority of the
cells. Our results from the adoptive transfer studies allow for the
possibility that it may be these cells that were originally recruited
because of their expression of NKG2D and that they then
recruited other cells via chemokines. This would suggest that
the development of insulitis in our older mice might be deter-
mined not only by the infectious history of the mouse but also
by an inflammatory trigger in the islets. However, our current
data do not allow us to definitively determine the cell type(s)
driving this spontaneous recruitment of lymphocytes. In addi-
tion, although the influx of lymphocytes was able to generate
appreciable inflammation, it, however, did not result in the
development of diabetes. This suggests that additional factors,
including the participation of antigen-specific T cells capable of
killing islet cells, may be required for the development of
disease.138 Immunity 36, 132–141, January 27, 2012 ª2012 Elsevier Inc.In contrast to our findings, two recent reports
(Lennon et al., 2009; Wang et al., 2010) demon-
strated that recruitment of T cells to islets wasa cell-autonomous event that required islet-antigen specificity.
The first (Lennon et al., 2009) used an elegant system of retro-
genic mice that expressed both islet-specific and nonspecific
CD4+ T cells. In this system there was no recruitment of T cells
specific for irrelevant antigen to islets even when there was
significant recruitment of diabetogenic T cells. One caveat to
these studies is that the nonspecific T cells were naive. T cell
activation alters receptor expression, including integrins and
chemokine receptors, allowing for T cell trafficking to tissues
(Denucci et al., 2009). It may be that only activated T cells, or
subsets of these cells, are able to be recruited in an antigen-
independent fashion because of differential receptor expression.
Our data suggest that NKG2D may be one of these receptors. In
the mouse, NKG2D is expressed only on activated CD8+ T cells
(Raulet, 2003), a cell type not investigated in the retrogenic
mouse study.
The authors of the second study (Wang et al., 2010) generated
a gene-targeted NOD mouse with a mutated islet-specific
glucose-6-phosphatase catalytic subunit-related protein (IGRP)
so that diabetogenic CD8+ T cells normally responsive to an
epitope derived from IGRP were no longer responsive. These
mice developed diabetes normally, but no IGRP-specific CD8+
T cells were found in inflamed islets. These authors did test
the possibility that activation was required for recruitment of
bystander T cells by adoptively transferring IGRP-specific
CD8+ T cells activated in vitro for 3 days into the mice. These
activated CD8+ T cells were also not recruited to the islets early
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on T cells early in culture (Markiewicz et al., 2005). Consistent
with our data, small numbers of these cells were recruited to
islets by 5 days after transfer, at a time when they presumably
expressed higher levels of NKG2D.
Amajor unanswered question is why NKG2D ligands would be
expressed in pancreatic islets. Are there circumstances that
induce expression of NKG2D ligands in islets normally, or does
pancreatic expression of these proteins occur only in diabetic-
prone individuals as a result of some dysregulation? It may be
that NKG2D ligands are normally expressed during times of
pancreatic stress, but diabetes ensues only when there are addi-
tional defects in immune tolerance resulting in the presence of
cells capable of killing b cells. One such stress may be the peri-
natal wave of b-cell death that is required for proper tissue re-
modeling of the pancreas and a proposed precipitating event
for the development of diabetes (Finegood et al., 1995; Kassem
et al., 2000; Petrik et al., 1998; Scaglia et al., 1997; Trudeau et al.,
2000; Turley et al., 2003). Another pancreatic stress proposed to
play a role in autoimmune diabetes development, viral infection
(Hober and Sauter, 2010), could also induce expression of
NKG2D ligands. Future studies will be required to determine
whether these or other stimuli induce expression of NKG2D
ligands in normal or diabetic-prone individuals.
In summary, by using transgenic mice with expression of the
NKG2D ligand RAEε in pancreatic islets, we demonstrate that
expression of NKG2D ligands in the pancreastic islets can
induce the recruitment of CTLs to islets. This recruitment was
independent of islet antigen specificity, but was dependent on
NKG2D engagement on the CTLs. Further, once CTLs are re-
cruited to islets, a large number of additional lymphocytes can
be recruited via chemokine secretion. Given that aberrant
NKG2D ligand expression has been linked to diabetes develop-
ment (Ogasawara et al., 2004), our results suggest that at least
one role for NKG2D in the development of diabetes may be to
mediate the recruitment of T cells to such pancreatic islets.EXPERIMENTAL PROCEDURES
Mice
All mice were housed under specific-pathogen-free conditions in the
Washington University School of Medicine animal facilities in accordance
with institutional guidelines. OT-I TCR transgenic, RIP-Cre, and RIP-OVA
mice were purchased from Jackson Laboratory. Hcst/ mice (Gilfillan et al.,
2002) were provided by M. Colonna (Washington University School of Medi-
cine). OT-1,-Rag1/ mice were purchased from Taconic Farms, Inc. The
Klrk1/ mice have been previously described (Zafirova et al., 2009).
To generate PCCALL-RAE1ε mice, the cDNA encoding RAE1ε (Carayanno-
poulos et al., 2002b) (provided by L. Carayannopoulos, Washington University
School of Medicine) was inserted into the multiple cloning site of the PCCALL2
vector (Lobe et al., 1999) (provided by A. Nagy, SLRI, Toronto, Canada). This
plasmid contains a chicken b-actin promoter, followed by a loxP-flanked gene
encoding b-geo (lacZ and neomycin resistance), and the RAE1ε cDNA inserted
30 of the 30 loxP site. This construct was transfected into C57BL/6/129 ES cells
(provided by B. Sleckman, Washington University School of Medicine). ES cell
clones were tested for their ability to express RAE1 after transient expression
of Cre. Selected ES cells were then microinjected into blastocysts by the
Washington University School of Medicine Department of Pathology and
Immunology microinjection core facility. Potential founders were screened
by PCR with the primers 50-GGAAATCCATCGCTCGACCA-30 and 50-TCA
CATCGCAAATGCAAATGC-30. The founder mouse was then backcrossed
five generations onto C57BL/6J (Jackson Laboratory).Tissue Sectioning and Staining
For immunofluorescent staining, pancreata were frozen in OCT freezing
medium (Tissue-Tek) and 5 mmsections were cut by theWashington University
School of Medicine Anatomic and Molecular Pathology Core. The sections
were fixed with cold acetone and (1) stained with a RAE1ε-specific antibody
(1:50) (R&D Systems) followed by a Cy3-conjugated anti-rat IgG (Jackson
Immunoresearch) and Hoechst stain (1 mg/ml) or (2) hematoxylin (Sigma
Aldrich) and eosin (Sigma Aldrich).
T Cell Adoptive Transfer Experiments
CTLs were generated in vitro by culturing splenocytes and lymph node cells
from OT-I TCR transgenic, OT-1- Hcst/, OT-1-Rag1/, or OT-1-Klrk1/
mice in IMDM + 10% FCS in 6-well plates (2.5 3 107 cells/well) with 1 mM
OVA peptide (SIINFEKL) (provided by P. Allen, Washington University School
of Medicine) for 5 days. Live cells were harvested with Ficoll-hypaque (GE
Healthcare) and were >98% CD8+TCRVa2+ (Figures S2 and S3). The cells
were labeled with 1 mM CFSE (Invitrogen) and injected i.v. (107 cells/mouse).
Pancreatic islets were harvested 24 hr later.
Islet Purification
Islets were purified with a ficoll gradient by published methods (Kelly et al.,
2003). Pancreata were minced and digested with collagenase IV (20 mg/ml)
(Sigma Aldrich). The digested pancreata were spun through a ficoll gradient
(25%–23%–20.5%–11%) and the islets harvested.
Flow Cytometry
A single-cell suspension was generated from isolated islets or spleens by
homogenization through a 40 mm cell strainer. Cells were stained with anti-
bodies purchased from BD Biosciences (CD45-PE-Cy7, CD4-PE, CD3ε-APC,
B220-PE-Cy5.5, TCR-gd-PE-Cy.5, CD11c-APC, NK1.1-FITC) or eBioscience
(CD8-750, CD11b-750), and dead cells were stained with 7-AAD (BD Biosci-
ences). The cells were then analyzed on a FACSCanto II flow cyotmeter (BD
Biosciences).
Chemokine Expression Analyses
Detection of Chemokine Transcripts
Single-cell suspensions from purified islets were separated into CD45+ and
CD45 fractions via a magnetic bead based separation system (Cellection
Biotin Binder Kit, Invitrogen; biotinylated anti-CD45, BD Biosciences). Total
RNA was isolated with Trizol (Invitrogen) followed by the RNeasy Mini Kit
(QIAGEN) according to the manufacturers’ protocols. Reverse transcription
was performed with the SABiosciences RT2 First Stand Kit (QIAGEN). The
cDNA was analyzed with the SABiosciences Mouse Chemokines and Recep-
tors RT2 Profiler PCR Array (QIAGEN) according to the manufacturer’s
protocol, a Prism 700 real-time PCR machine (Applied Biosciences), and the
SABiosciences Web-Based PCR Array Data Analysis software. Transcripts
in total islets were compared between RIP-RAE1ε + CTL and control + CTL
(n = 2), and RIP-RAE1ε + CTL and RIP-RAE1εwithout CTL (n = 1). The average
fold upregulation in islets from RIP-RAE1ε + CTL is shown. The expression of
these transcripts was then compared between CD45+ and CD45 cell popula-
tions from RIP-RAE1ε mice + CTL (n = 2).
Detection of Chemokine Proteins
Purified islets from RIP-RAE1ε and control PCCALL-RAE1ε and RIP-Cre
mice that had or had not received OT-I CTLs were cultured overnight.
The supernatants from these cultures were then analyzed with the Bio-Pex
Pro mouse cytokine 23-plex assay (Bio-Rad) and a Bio-Plex workstation
(Bio-Rad).
Streptozotocin Injection
After 6 hr of fasting, mice were injected with streptozotocin (Sigma Aldrich)
in citrate buffer (pH 4.5) i.p. Two streptozotocin injections were given 24 hr
apart.
Influenza Infection
Mice were anesthetized with ketamine and xylazine. 100 PFU of influenza A,
strain WSN/33 (provided by H. Virgin, Washington University School of
Medicine) was given i.n.Immunity 36, 132–141, January 27, 2012 ª2012 Elsevier Inc. 139
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